Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-714

I've been thru a number of scenarios here and researched until I'm content that my relatively small holding will do well.

End of the day what I come back to is one simple point. In the weeks before the testing angle emerge the SP traded down at 8.5c, management were not buying suggesting they didn't see significant upside.

In the raise management have dipped into their pockets to buy shares at 22c to the tune of $1m, a significant validation of their strategy. Now the one thing you can almost always rely on is greed. Management didn't buy as an act of charity, they bought because they, with all the info at hand believed they can make money.

This suggests to me that what will unfold in coming weeks will significantly increase the value of the company. I don't think we're talking about small numbers of tests.

I'm not expecting to be holding this for years awaiting a dividend and I doubt too many others posting here will be either but the simple fact is that those holding the cards obviously like the hand about to be dealt.